# The improved health utility of once‐weekly subcutaneous semaglutide 2.4 mg compared with placebo in the <scp>STEP</scp> 1‐4 obesity trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-improved-health-utility-of-once-weekly-subcutaneous-semaglutide-2-4-mg/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jakob Bue Bjørner,Sára Larsen,Christopher Lübker,Thomas Holst‐Hansen |
| Citations | 5 |
| DOI | 10.1111/dom.15090 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15090 |
| OpenAlex ID | https://openalex.org/W4365482992 |
| PMID | 37055712 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Jakob Bue Bjørner](https://scholariq.org/researchers/jakob-bue-bj-rner/)
- [Christopher Lübker](https://scholariq.org/researchers/christopher-lubker/)
- [Sára Larsen](https://scholariq.org/researchers/sara-larsen/)
- [Thomas Holst‐Hansen](https://scholariq.org/researchers/thomas-holst-hansen/)

## Paper funders

- [Novo Nordisk](https://scholariq.org/funders/novo-nordisk/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.